FactSet Research Systems Inc. (FDS) reported solid first-quarter results on Thursday, beating analyst expectations across the board. Yet somehow, Wall Street decided this was the perfect moment to lower price targets. Welcome to the logic of financial markets.

The financial data and analytics provider posted first-quarter sales of $607.6 million, comfortably ahead of the $600.5 million analysts were expecting and marking a 6.9% year-over-year increase. Adjusted earnings per share came in at $4.51, beating the consensus estimate of $4.37. By most measures, this was a win.

CEO Sanoke Viswanathan seemed pleased with the performance, stating that "FactSet's strong start to the year underscores the quality of our data and products and the strategic role our platform and analytical services play across the financial ecosystem."

The company also reaffirmed its fiscal 2026 guidance, projecting adjusted EPS between $16.90 and $17.60 compared to the consensus of $17.38. Revenue guidance landed at $2.423 billion to $2.448 billion, versus the $2.442 billion consensus estimate. FactSet also expects organic annual subscription value (ASV) of $100 million to $150 million and an adjusted operating margin between 34.0% and 35.5%.

Investors responded positively to the news, pushing FactSet Research shares up 4.6% to $286.00 on Friday.

Analyst Actions Following Earnings

But not everyone was celebrating. Two prominent analysts made significant changes to their outlook on the stock following the earnings announcement.

Stifel analyst Shlomo Rosenbaum maintained a Hold rating on FactSet Research but lowered his price target from $372 to $295. That's a substantial reduction, suggesting concerns about the company's valuation or growth trajectory despite the solid quarter.

Goldman Sachs analyst George Tong took an even more bearish stance, maintaining a Sell rating while cutting his price target from $282 to $253. With shares trading at $286 after Friday's pop, Goldman's view implies notable downside ahead.

The disconnect between strong quarterly results and reduced price targets suggests analysts may be looking beyond the immediate numbers toward longer-term growth concerns or valuation considerations that didn't make headlines in the earnings release.